Apollo Endosurgery Upgraded To Overweight From Neutral At Piper Sandler By: TalkMarkets November 30, 2020 at 05:12 AM EST Piper Sandler analyst Adam Maeder upgraded Apollo Endosurgery to Overweight from Neutral with a price target of $5, up from $2. Read More >> Related Stocks: Apollo Endosurgery Inc